Document is current
Any future updates will be listed below
-
Authors
Lapi, Francesco http://orcid.org/0000-0002-4342-9128
Marconi, Ettore
Medea, Gerardo
Parretti, Damiano
Piccinni, Carlo
Maggioni, Aldo Pietro
Cricelli, Claudio
- License Information
-
More Information
Article History
Received: 14 February 2023
Accepted: 6 June 2023
First Online: 20 June 2023
Compliance with ethical standards
:
: F.L. and E.M. provided consultancies in protocol preparation for epidemiological studies and data analyses for Roche Diagnostics, Astra Zeneca, Novartis, MSD. G.M., D.P. and C.C. provided clinical consultancies for Roche Diagnostics, Astra Zeneca, Novartis, MSD. A.P.M. received personal fees for the participation in clinical studies supported by Bayer, Novartis, Fresenius and Astra Zeneca, outside the present work. C.P. has no conflict of interest to disclose.
: The study protocol was approved by the Scientific Committee of the Italian College of General Practitioners and Primary Care. This study followed the principles of the Declaration of Helsinki, and it is compliant with the ENCePP (European Network of Centers for Pharmacoepidemiology and Pharmacovigilance) Guide on Methodological Standards in Pharmacoepidemiology. Furthermore, as this is a retrospective, non‐interventional, observational study, the data were fully anonymized. There is therefore no need for informed consent (Italian Drug Agency note dated 3rd of August 2007).
